Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 153 citing articles:

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Jeffrey D Stanaway, Ashkan Afshin, Emmanuela Gakidou, et al.
The Lancet (2018) Vol. 392, Iss. 10159, pp. 1923-1994
Open Access | Times Cited: 4282
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1507
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Weimar Kunz Sebba Barroso, Cibele Isaac Saad Rodrigues, Luiz Aparecido Bortolotto, et al.
Arquivos Brasileiros de Cardiologia (2021) Vol. 116, Iss. 3, pp. 516-658
Open Access | Times Cited: 779
Blood pressure and the new ACC/AHA hypertension guidelines
John M. Flack, Bemi Adekola
Trends in Cardiovascular Medicine (2019) Vol. 30, Iss. 3, pp. 160-164
Open Access | Times Cited: 469
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019

Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S103-S123
Open Access | Times Cited: 417
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021

Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S125-S150
Closed Access | Times Cited: 399
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S158-S190
Open Access | Times Cited: 327
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Francis S. Willard, Jonathan D. Douros, M Gabe, et al.
JCI Insight (2020) Vol. 5, Iss. 17
Open Access | Times Cited: 301
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 278
Sex Differences in Hypertension: Where We Have Been and Where We Are Going
Lindsey A. Ramirez, Jennifer C. Sullivan
American Journal of Hypertension (2018) Vol. 31, Iss. 12, pp. 1247-1254
Open Access | Times Cited: 179
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S179-S218
Open Access | Times Cited: 177
Polypill for Cardiovascular Disease Prevention in an Underserved Population
Daniel Muñoz, Prince Uzoije, Cassandra Reynolds, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 12, pp. 1114-1123
Open Access | Times Cited: 165
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S144-S174
Open Access | Times Cited: 165
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial
Clara K Chow, Emily Atkins, Graham S. Hillis, et al.
The Lancet (2021) Vol. 398, Iss. 10305, pp. 1043-1052
Open Access | Times Cited: 112
Hypertension in Low- and Middle-Income Countries
Aletta E. Schutte, Nikhil Srinivasapura Venkateshmurthy, Sailesh Mohan, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 808-826
Open Access | Times Cited: 111
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 98
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S207-S238
Closed Access | Times Cited: 27
Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients
Jennifer Cautela, Jean‐Michel Tartière, Alain Cohen‐Solal, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 8, pp. 1357-1365
Open Access | Times Cited: 100
Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005–2016
Catherine G. Derington, Jordan B. King, Jennifer S. Herrick, et al.
Hypertension (2020) Vol. 75, Iss. 4, pp. 973-981
Open Access | Times Cited: 99
Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension
Abdul Salam, Raju Kanukula, Emily Atkins, et al.
Journal of Hypertension (2019) Vol. 37, Iss. 9, pp. 1768-1774
Closed Access | Times Cited: 83
Medication adherence in cardiovascular medicine
S. Simon, Vinay Kini, Andrew Levy, et al.
BMJ (2021), pp. n1493-n1493
Closed Access | Times Cited: 81
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
Dexter Canoy, Milad Nazarzadeh, Emma Copland, et al.
Current Cardiology Reports (2022) Vol. 24, Iss. 7, pp. 851-860
Open Access | Times Cited: 53
Essential Components from Plant Source Oils: A Review on Extraction, Detection, Identification, and Quantification
Muhammad Abdul Rahim, Hudda Ayub, Aqeela Sehrish, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6881-6881
Open Access | Times Cited: 39
Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension
Nelson Wang, Phidias Rueter, Emily Atkins, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 6, pp. 606-606
Open Access | Times Cited: 22
Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria
Dike Ojji, Abdul Salam, Mahmoud U. Sani, et al.
JAMA (2024)
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top